Drug News
-
FDA Issues Warning on Toxic Tejocote Root Supplements Contaminated with Yellow Oleander
In September 2023, the Centers for Disease Control and Prevention published a report of several tejocote root products found to…
Read More » -
Megadyne Medical Products, Inc. Issues Recall for Mega Soft Universal Patient Return Electrode Due to Burn Risks
Megadyne Medical Products, Inc. has initiated a recall of its Mega Soft Universal Patient Return Electrode, Mega Soft Universal Dual,…
Read More » -
FDA Approves Vaporized Hydrogen Peroxide as Established Sterilization Method for Medical Devices
In a significant development, the U.S. Food and Drug Administration (FDA) has officially recognized vaporized hydrogen peroxide (VHP) as an…
Read More » -
Chiesi Group and Oak Hill Bio Collaborate on OHB-607, a Neonatal Therapy
Chiesi Group, an international biopharmaceutical and healthcare group, and Oak Hill Bio, a neonatology and rare disease therapeutics company, have…
Read More » -
AbbVie Introduces PRODUODOPA® for Advanced Parkinson’s Disease in the European Union
AbbVie (NYSE: ABBV), a leading global healthcare company, has announced the launch of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union. This…
Read More » -
Medtronic’s Percept™ RC Neurostimulator, Empowered by BrainSense™ Technology, Receives FDA Approval
Medtronic plc, a global leader in healthcare technology, proudly announced today the approval of its Percept™ RC Deep Brain Stimulation…
Read More » -
Bayer Pushes Forward with U.S. Expansion Despite Setback in Blood Thinner Drug Development
German pharmaceutical giant Bayer (BAYGn.DE) remains undeterred in its plans for expansion into the U.S., reaffirming its commitment to the…
Read More » -
GSK Expands Respiratory Portfolio through $1.4 Billion Aiolos Bio Deal
British pharmaceutical giant GlaxoSmithKline (GSK) announced a strategic move to bolster its respiratory diseases portfolio with the acquisition of Aiolos…
Read More » -
Technavio Predicts Significant Growth in Assisted Reproductive Technology (ART) Market
According to the latest report by Technavio Research, the Assisted Reproductive Technology (ART) Market is poised for substantial growth, expecting…
Read More » -
Projected Growth for Human Microbiome Therapeutics Market to Surpass USD 730 Million by 2027
The global human microbiome therapeutics market is poised for a groundbreaking surge, anticipating a substantial growth of USD 732.95 million…
Read More »